Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

NCT01189032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: DE-089 ophthalmic solution
DRUG: DE-089 ophthalmic solution
DRUG: Placebo ophthalmic solution

Sponsor

Santen Pharmaceutical Co., Ltd.